Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: October 2022

MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Innovative Robot Roadshow Makes Stop in Dallas

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), and its Robot Roadshow are spending the day in Dallas. The roadshow is a free, engaging experiential event that is designed to provide potential clients, media and investors with … Continue reading

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Release of Q3 2022 Results, Conference Call

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has announced that it will provide a business update and release its financial results for the third quarter of 2022 following the close of the market on … Continue reading

Posted in Cepton Inc. CPTN | Leave a comment

MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Agreement with Columbia University to Extend Research Pact

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, has entered into an agreement with Columbia University to extend its current research partnership efforts. The agreement outlines certain assets that are currently … Continue reading

Posted in Silo Pharma Inc. SILO | Leave a comment

MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Reports Assay Results from Iska Iska Drills

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, has been conducting an ongoing drilling program at its Iska Iska silver-tin polymetallic … Continue reading

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Releases Positive Results From Silver-Tin Polymetallic Project in Bolivia

Eloro Resources is an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru, and Quebec Company released positive results from 21 diamond drill holes at Iska Iska Bolivia project revealing silver, tin, zinc, … Continue reading

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Expands Production Facilities; Names CFO to Oversee Company’s Next Growth Stage

The Renewable Natural Gas (“RNG”) market is forecast to grow to an annual market size of $72.13 billion by 2027 EverGen purchased a 66% stake in Albert-based agri operation, GrowTEC for a gross consideration of $2.1 million EverGen are in … Continue reading

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment

Correlate Infrastructure Partners Inc. (CIPI) Expanding as Solar Adoption is Projected to Grow by 30% in 2022

Correlate’s strategic investments in clean electrification solutions and commercial solar infrastructure have earned the company a growing customer base, and an opportunity pipeline of over $100 million in commercial projects The company recognizes the rise in EV and solar adoption … Continue reading

Posted in Correlate Infrastructure Partners Inc. CIPI | Leave a comment

MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Featured in BioWorld(TM) MedTech Article

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed an innovative platform for heart attack detection anytime, anywhere, was featured in a recent BioWorld(TM) MedTech article. “HeartBeam Inc. has been awarded a patent for what it called ‘the first … Continue reading

Posted in HeartBeam Inc. BEAT | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Continues Focus to Create the Best Psychedelic Therapies for Patients

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, is conducting a phase 1/2a trial evaluating CYB003, its lead investigational molecule and the first-ever novel psilocybin analog … Continue reading

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Anticipating 2023 IND Application for Secondary Portfolio Candidate

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical innovator, is currently conducting a potentially pivotal global phase 2 clinical trial in humans to test the effectiveness of its anti-glioblastoma (“GBM”) drug candidate – Berubicin. Testing of Berubicin resulted in a notable success … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment